How Structured Protocol Authoring Reduces Protocol Amendment Rework
A closer look at how governed clinical content reduces duplicated edits, downstream misalignment, and amendment review burden across the protocol
ePI and FHIR: A Practitioner’s Walkthrough of the FHIR ePI Implementation Guide
What Pharma Companies Need to Know About ePI FHIR When the European medicines regulatory network adopted the EU ePI Common
ePI vs SPL: Preparing for EU Electronic Product Information and FDA Structured Product Labeling
How EU ePI and FDA SPL Create Parallel Labeling Workflows A director of Regulatory Affairs at a mid-sized pharma company
When EMA Says Go: What the ePI Mandate Actually Requires From Your Content Operations
EMA ePI requirements are moving from roadmap item to operational mandate. This article explains what the shift means for labeling, regulatory, and CMC content operations.
Clinical Documentation Guide
This paper explains how escalating trial complexity, regulatory scrutiny, and interoperability demands have made traditional document-based clinical documentation unsustainable.
Structured Content for Clinical Documents: The Future of Regulatory Writing
The Challenge: Fragmented Authoring and Redundant Writing in Clinical Operations For decades, clinical documentation has been both the foundation and
AI in Regulatory Affairs: Cutting Through the Hype
How governed, structured content enables responsible AI in life sciences. Artificial intelligence (AI) has moved from a buzzword to a